Deutsche Bank
NVO

Deutsche Bank’s Novo Nordisk NVO Stock Holding History

Deutsche Bank’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-10,510
Closed -$2K – 5676
2013
Q2 		$2K Buy
+10,510
New +$175K ﹤0.01% 5175

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Deutsche Bank's NVO Position: Q2 2026 in Review

Deutsche Bank reduced its Novo Nordisk (NVO) stake by 1.6% in Q2 2026, selling an estimated $78K and leaving 111,505 shares worth $5.35M. The position accounts for ﹤0.01% of the portfolio, ranked #1339.

Deutsche Bank first reported a position in NVO in Q2 2013 and has held it in 53 quarters since. The position peaked at $65.4M in Q2 2023. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Deutsche Bank held 111,505 shares of Novo Nordisk worth $5.35M as of Q2 2026.
  • Deutsche Bank sold 1,816 Novo Nordisk shares in Q2 2026, an estimated $78K.
  • Novo Nordisk made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #1339 holding.
  • Deutsche Bank first reported a position in Novo Nordisk in Q2 2013 and has held it in 53 quarters since.
  • Deutsche Bank's Novo Nordisk position peaked at $65.4M in Q2 2023.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.